Drug ID: | NPD5123 |
Drug Name: | |
Molecular Formula: | C22H26O5 |
Canonical SMILES: | CCCc1cc(=O)oc2c1c1OC(C)(C)C=Cc1c1c2C(O)C(C(O1)C)C |
Standard InCHI: | InChI=1S/C22H26O5/c1-6-7-13-10-15(23)26-21-16(13)20-14(8-9-22(4,5)27-20)19-17(21)18(24)11(2)12(3)25-19/h8-12,18,24H,6-7H2,1-5H3 |
Standard InCHIKey: | NIDRYBLTWYFCFV-UHFFFAOYSA-N |
Max Developmental Stage: | Clinical (unspecified phase) |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB016345 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | |
CAS Number |
Molecular Weight | 370.18 |
ALogP | 0.2774 |
MLogP | 3.33 |
XLogP | 3.505 |
HDA | 2 |
HBD | 1 |
Rotatable Bonds | 8 |
TPSA | 64.99 |
RO5 Violation | 0 |